CD8A and neoplasm: DC therapy induces the infiltration of tumor-specific CD8+ T cells and upregulates PD-1 expression on these TILs, which could render tumors with low TIL numbers susceptible to anti-PD-(L)1 treatment.91, 92, 93, 94